{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:25:09Z","timestamp":1756571109077,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,22]]},"DOI":"10.7759\/cureus.79473","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T02:04:41Z","timestamp":1740276281000},"source":"Crossref","is-referenced-by-count":1,"title":["Potential of a Novel Patient-Reported Outcome Assessment Method Utilizing Illustrations in Rheumatoid Arthritis"],"prefix":"10.7759","author":[{"given":"Kensuke","family":"Koyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryousuke","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac017","article-title":"Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication","volume":"33","author":"Kawahito Y","year":"2023","unstructured":"Kawahito Y, Morinobu A, Kaneko Y, et al.. Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication. Mod Rheumatol. 2023, 33:21-35. 10.1093\/mr\/roac017","journal-title":"Mod Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen JS","year":"2023","unstructured":"Smolen JS, Landew\u00e9 RB, Bergstra SA, et al.. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023, 82:3-18. 10.1136\/ard-2022-223356","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.41752","article-title":"2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel L","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR, et al.. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2021, 73:1108-23. 10.1002\/art.41752","journal-title":"Arthritis Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2019.1660028","article-title":"A large observational cohort study of rheumatoid arthritis, IORRA: providing context for today's treatment options","volume":"30","author":"Yamanaka H","year":"2020","unstructured":"Yamanaka H, Tanaka E, Nakajima A, et al.. A large observational cohort study of rheumatoid arthritis, IORRA: providing context for today's treatment options. Mod Rheumatol. 2020, 30:1-6. 10.1080\/14397595.2019.1660028","journal-title":"Mod Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries JF","year":"1980","unstructured":"Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980, 23:137-45. 10.1002\/art.1780230202","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.4.463","article-title":"Use of the short form 36 (SF36) for health status measurement in rheumatoid arthritis","volume":"36","author":"Talamo J","year":"1997","unstructured":"Talamo J, Frater A, Gallivan S, Young A. Use of the short form 36 (SF36) for health status measurement in rheumatoid arthritis. Br J Rheumatol. 1997, 36:463-9. 10.1093\/rheumatology\/36.4.463","journal-title":"Br J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.5.551","article-title":"Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D)","volume":"36","author":"Hurst NP","year":"1997","unstructured":"Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol. 1997, 36:551-9. 10.1093\/rheumatology\/36.5.551","journal-title":"Br J Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001707","article-title":"Use and detailed metric properties of patient-reported outcome measures for rheumatoid arthritis: a systematic review covering two decades","volume":"7","author":"K\u00fc\u00e7\u00fckdeveci AA","year":"2021","unstructured":"K\u00fc\u00e7\u00fckdeveci AA, Elhan AH, Erdo\u011fan BD, et al.. Use and detailed metric properties of patient-reported outcome measures for rheumatoid arthritis: a systematic review covering two decades. RMD Open. 2021, 7:10.1136\/rmdopen-2021-001707","journal-title":"RMD Open"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20560","article-title":"Measures of health status and quality of life in juvenile rheumatoid arthritis: Pediatric Quality of Life Inventory (PedsQL) Rheumatology Module 3.0, Juvenile Arthritis Quality of Life Questionnaire (JAQQ), Paediatric Rheumatology Quality of Life Scale (PRQL), and Childhood Arthritis Health Profile (CAHP)","volume":"63 Suppl 11","author":"Carle AC","year":"2011","unstructured":"Carle AC, Dewitt EM, Seid M. Measures of health status and quality of life in juvenile rheumatoid arthritis: Pediatric Quality of Life Inventory (PedsQL) Rheumatology Module 3.0, Juvenile Arthritis Quality of Life Questionnaire (JAQQ), Paediatric Rheumatology Quality of Life Scale (PRQL), and Childhood Arthritis Health Profile (CAHP). Arthritis Care Res (Hoboken). 2011, 63 Suppl 11:S438-45. 10.1002\/acr.20560","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac152","article-title":"Illustrations of rheumatoid arthritis symptoms to promote communication between patients and physicians","volume":"34","author":"Kaneko Y","year":"2023","unstructured":"Kaneko Y, Hasegawa M, Ikeda K, Nakano K, Kadono Y, Tanaka Y, Takeuchi T. Illustrations of rheumatoid arthritis symptoms to promote communication between patients and physicians. Mod Rheumatol. 2023, 34:87-91. 10.1093\/mr\/roac152","journal-title":"Mod Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha D","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, et al.. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010, 62:2569-81. 10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo ML","year":"1995","unstructured":"Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38:44-8. 10.1002\/art.1780380107","journal-title":"Arthritis Rheum"},{"key":"ref13","article-title":"A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches","volume":"9","author":"Bombardier C","year":"1982","unstructured":"Bombardier C, Tugwell P. A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches. J Rheumatol. 1982, 9:753-7.","journal-title":"J Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg072","article-title":"A simplified disease activity index for rheumatoid arthritis for use in clinical practice","volume":"42","author":"Smolen JS","year":"2003","unstructured":"Smolen JS, Breedveld FC, Schiff MH, et al.. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford). 2003, 42:244-57. 10.1093\/rheumatology\/keg072","journal-title":"Rheumatology (Oxford)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/ar1740","article-title":"Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score","volume":"7","author":"Aletaha D","year":"2005","unstructured":"Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005, 7:R796-806. 10.1186\/ar1740","journal-title":"Arthritis Res Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05451-3","article-title":"Clinical conditions needed to acquire sustained functional remission in rheumatoid arthritis patients","volume":"40","author":"Koizumi R","year":"2021","unstructured":"Koizumi R, Koyama K, Wako M, Ohba T, Takayama Y, Haro H. Clinical conditions needed to acquire sustained functional remission in rheumatoid arthritis patients. Clin Rheumatol. 2021, 40:1751-7. 10.1007\/s10067-020-05451-3","journal-title":"Clin Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097952","article-title":"Multi-dimensional health assessment questionnaire in China: reliability, validity and clinical value in patients with rheumatoid arthritis","volume":"9","author":"Song Y","year":"2014","unstructured":"Song Y, Zhu LA, Wang SL, Leng L, Bucala R, Lu LJ. Multi-dimensional health assessment questionnaire in China: reliability, validity and clinical value in patients with rheumatoid arthritis. PLoS One. 2014, 9:e97952. 10.1371\/journal.pone.0097952","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2014.948587","article-title":"Validation of RAPID3 using a Japanese version of Multidimensional Health Assessment Questionnaire with Japanese rheumatoid arthritis patients: characteristics of RAPID3 compared to DAS28 and CDAI","volume":"25","author":"Yokogawa N","year":"2015","unstructured":"Yokogawa N, Kaneko T, Nagai Y, et al.. Validation of RAPID3 using a Japanese version of Multidimensional Health Assessment Questionnaire with Japanese rheumatoid arthritis patients: characteristics of RAPID3 compared to DAS28 and CDAI. Mod Rheumatol. 2015, 25:264-9. 10.3109\/14397595.2014.948587","journal-title":"Mod Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49380-y","article-title":"Comprehensive relationship between disease activity indices, mTSS, and mHAQ and physical function evaluation and QOL in females with rheumatoid arthritis","volume":"13","author":"Nagafusa T","year":"2023","unstructured":"Nagafusa T, Mizushima T, Suzuki M, Yamauchi K. Comprehensive relationship between disease activity indices, mTSS, and mHAQ and physical function evaluation and QOL in females with rheumatoid arthritis. Sci Rep. 2023, 13:21905. 10.1038\/s41598-023-49380-y","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s100670050155","article-title":"How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional study","volume":"19","author":"Birrell FN","year":"2000","unstructured":"Birrell FN, Hassell AB, Jones PW, Dawes PT. How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional study. Clin Rheumatol. 2000, 19:195-9. 10.1007\/s100670050155","journal-title":"Clin Rheumatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei181","article-title":"Comparison of the Health Assessment Questionnaire (HAQ) and the modified HAQ (MHAQ) in patients with rheumatoid arthritis","volume":"45","author":"Uhlig T","year":"2006","unstructured":"Uhlig T, Haavardsholm EA, Kvien TK. Comparison of the Health Assessment Questionnaire (HAQ) and the modified HAQ (MHAQ) in patients with rheumatoid arthritis. Rheumatology (Oxford). 2006, 45:454-8. 10.1093\/rheumatology\/kei181","journal-title":"Rheumatology (Oxford)"},{"key":"ref22","article-title":"Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis","volume":"35","author":"Linde L","year":"2008","unstructured":"Linde L, S\u00f8rensen J, Ostergaard M, H\u00f8rslev-Petersen K, Hetland ML. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol. 2008, 35:1528-37.","journal-title":"J Rheumatol"},{"key":"ref23","article-title":"Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis","volume":"32","author":"Cella D","year":"2005","unstructured":"Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005, 32:811-9.","journal-title":"J Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13897","article-title":"Fatigue and associated factors in a multi-ethnic cohort of rheumatoid arthritis patients","volume":"23","author":"Lee HJ","year":"2020","unstructured":"Lee HJ, Pok LS, Ng CM, Yahya F, Sockalingam S, Tee YC, Raja J. Fatigue and associated factors in a multi-ethnic cohort of rheumatoid arthritis patients. Int J Rheum Dis. 2020, 23:1088-93. 10.1111\/1756-185X.13897","journal-title":"Int J Rheum Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181286","article-title":"Association of 17 definitions of remission with functional status in a large clinical practice cohort of patients with rheumatoid arthritis","volume":"47","author":"Carvalho PD","year":"2020","unstructured":"Carvalho PD, Ferreira RJ, Landew\u00e9 R, et al.. Association of 17 definitions of remission with functional status in a large clinical practice cohort of patients with rheumatoid arthritis. J Rheumatol. 2020, 47:20-7. 10.3899\/jrheum.181286","journal-title":"J Rheumatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216151","article-title":"Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019","volume":"79","author":"Winthrop KL","year":"2020","unstructured":"Winthrop KL, Weinblatt ME, Bathon J, et al.. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019. Ann Rheum Dis. 2020, 79:88-93. 10.1136\/annrheumdis-2019-216151","journal-title":"Ann Rheum Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247594","article-title":"Unmet needs and current challenges of rheumatoid arthritis: difficult-to-treat rheumatoid arthritis and late-onset rheumatoid arthritis","volume":"13","author":"Takanashi S","year":"2024","unstructured":"Takanashi S, Kaneko Y. Unmet needs and current challenges of rheumatoid arthritis: difficult-to-treat rheumatoid arthritis and late-onset rheumatoid arthritis. J Clin Med. 2024, 13:10.3390\/jcm13247594","journal-title":"J Clin Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2017.1416940","article-title":"Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review","volume":"28","author":"Ishida M","year":"2018","unstructured":"Ishida M, Kuroiwa Y, Yoshida E, et al.. Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review. Mod Rheumatol. 2018, 28:789-99. 10.1080\/14397595.2017.1416940","journal-title":"Mod Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/330728-potential-of-a-novel-patient-reported-outcome-assessment-method-utilizing-illustrations-in-rheumatoid-arthritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T02:04:43Z","timestamp":1740276283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/330728-potential-of-a-novel-patient-reported-outcome-assessment-method-utilizing-illustrations-in-rheumatoid-arthritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.79473","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,22]]}}}